Helicos BioSciences (HLCS) Stays Volatile

September 8, 2009 · Filed Under M&A, R&D 

Helicos BioSciences (HLSC) is up 30% on news that the RIKEN Yokohama Institute Omics Science Center (OSC) has agreed to purchase four Helicos™ Genetic Analysis Systems. The transaction represents the first multisystem sale of the Helicos system to a large genome center. Shipments are expected to take place in September, with one system remaining in Cambridge to be used in a scientific collaboration between the two parties that began last year.

Helicos has risen by a remarkable amount over the last month, going from $.60 to $3.25. Recently it retained Thomas Weisel Partners to look for partners or potentially a buyer.

If Thomas Weisel is not successful, the shares are in for some punishment.

Douglas A. McIntyre

Tags:

Comments

Comments are closed.

    Subscribe to BioHealth Investor BioHealth Investor RSS Feed